Tilray France

Paris, FranceFounded 2021

Medical & Pharma NASDAQ: TLRY tilray.com

Share:X / Twitter LinkedIn Suggest a correction

About Tilray France

Tilray France is the French operations division of Canadian cannabis giant Tilray, participating in France's medical cannabis pilot program launched in 2021.

Key Facts

1Selected as a supplier for France's medical cannabis experimentation program
2Part of Tilray Brands, one of the world's largest cannabis companies

Latest News

Tilray Accelerates Medical Cannabis Expansion Despite Sector Headwinds

2d ago

TLRY pushes international medical platform growth as cannabis stocks face regulatory uncertainty and market volatility

Tilray's Panama Push Tests International Cannabis Expansion Strategy

9d ago

TLRY explores Central American operations as cannabis companies seek growth beyond saturated North American markets amid regulatory headwinds.

Tilray Stock Eyes Inflection Point as Cannabis Markets Shift

9d ago

TLRY approaches critical juncture amid evolving regulatory landscape and operational restructuring efforts across North American cannabis markets.

TLRY Diversifies Beyond Cannabis With Craft Beverage Expansion

12d ago

Tilray Brands leverages dual-market strategy combining cannabis operations with craft beverage acquisitions to drive revenue growth and market expansion.

Tilray Positioned for US Cannabis Rescheduling Windfall

12d ago

TLRY stock could surge as federal rescheduling opens massive US market opportunities for the Canadian cannabis giant's established operations.

View all TLRY news

Frequently Asked Questions

Is medical cannabis legal in France?

France launched a medical cannabis pilot program in 2021, allowing select patients to access cannabis-based treatments through authorized suppliers like Tilray.